Syrup Medical
1 / 5
Indocyanine green (ICG) is a near-infrared fluorescent dye. Protein-bound ICG can be excited by external light with a wavelength range of 750 ~ 810 nm and emits near-infrared light at approximately 840nm. Its half-life in blood is 3 ~ 5 minutes. After entering the blood and binding to protein, it is absorbed by liver cells, enters the intestine through the biliary tract, and is finally excreted with feces.
This product is the first indocyanine green injection in China to pass double consistency evaluations, ensuring high purity, low impurity content, and optimized storage conditions for stable and reliable diagnosis and treatment.
Indications: Detection of choroidal neovascularization, macular lesions, intraocular tumors, and retinal vascular lesions; intraoperative staining of capsule and internal limiting membrane.
Advantages: Provides clear choroidal vascular images for accurate diagnosis. In cataract and retinal surgery, fluorescent staining helps identify target membranes accurately and reduces complications.
Indications: Evaluation of liver reserve function, liver tumor imaging, liver segment identification, and biliary tract development observation.
Advantages: Optimal method to evaluate liver reserve function due to rapidity and safety. Fluorescence helps identify liver structure clearly to improve surgical precision.
Indications: Accurate localization of tumors, imaging of the lymphatic system, and assessment of blood supply.
Advantages: The fluorescence signal makes target judgment more intuitive, enhancing visibility during operations.
Product range includes high-end medical devices (fluorescence imaging series), fluorescence contrast agents (ICG, targeted series), and core components (CMOS camera modules, endoscopes), providing a full-chain solution used in over 500 large hospitals.
Focusing on core technologies such as molecular fluorescence, Raman spectroscopy, AI, and computer-aided drug molecular design (CADD). The mission is to become a global leader in molecular fluorescence technology through the synergy of medical devices and pharmaceuticals.
Holding 131 core invention patents and 7 US invention patents. Strategic partnerships have been established with leading international companies, extending operations to more than 10 overseas countries.
